|
Endometrium
|   |
|
Endometrium
| |
- For hysterectomy specimens with carcinoma, carcinosarcoma (malignant mixed Müllerian tumor) and neuroendocrine carcinomas arising in the endometrium
Specimen and Surgical Procedure
Specimen, procedure...................................................................
Lymph nodes submitted and/or identified in the specimen................. yes/no
Tumor
Tumor size.................................................................................. ___ cm
Histologic type.............................................................................
Histologic grade (FIGO grade for endometrioid and mucinous type only)
Architectural grade.............................................................
Nuclear grade....................................................................
Composite FIGO grade........................................................
Myometrial invasion..................................................................... not identified/present
Maximum depth of invasion (in mm)..................................... __mm
Myometrial thickness (in mm).............................................. __mm
Percentage of myometrial invasion: ___ % (or estimated less than or greater than or equal to 50% myometrial invasion)
Uterine serosa involvement...........................................................not identified/present
Cervical stromal involvement.........................................................not identified/present
Other tissue/organ involvement.....................................................
Lymphovascular invasion.............................................................. not identified/present
Final Margins (required only if cervix and/or parametrium/paracervix is involved by carcinoma)
Ectocervical/vaginal cuff margin........................................................involved/uninvolved
Parametrial/paracervical margin........................................................involved/uninvolved
Lymph Nodes** (required only if lymph nodes are present in the specimen)
Pelvic lymph nodes (Includes parametrial, obturator, internal iliac (hypogastric), external iliac, common iliac, sacral and presacral nodes)
Total number of pelvic nodes examined (sentinel and non-sentinel): _____
Number of pelvic sentinel nodes examined: _____
Laterality of pelvic node(s) examined: ____________________________
Laterality of node(s) with tumor (if applicable): ____________________________
Number with macrometastasis (greater than 2 mm): _____
Number with micrometastasis (greater than 0.2 mm and up to 2 mm): _____
Number with isolated tumor cells (0.2 mm or less): _____
Para-aortic lymph nodes
Total number of para-aortic nodes examined (sentinel and non-sentinel): _____
Number of para-aortic sentinel nodes examined: _____
Laterality of para-aortic node(s) examined: ____________________________ Laterality of node(s) with tumor (if applicable): ____________________________
Number with macrometastasis (greater than 2 mm): _____
Number with micrometastasis (greater than 0.2 mm and up to 2 mm): _____
Number with isolated tumor cells (0.2 mm or less) (if applicable): _____
Pathologic stage (AJCC 8th ed.)............................................................pT__N__M__